Expression cloning human and rat renal cortex Na/Pi cotransporters: behind the scenes in the Murer laboratory by Magagnin S & Werner A
INVITED REVIEW
Expression cloning human and rat renal cortex Na/Pi
cotransporters: behind the scenes in the Murer laboratory
Simona Magagnin1 & Andreas Werner2
Received: 5 June 2018 /Revised: 9 August 2018 /Accepted: 15 August 2018
# The Author(s) 2018
Abstract
In the pre-genomic era, the cloning of a cDNA represented a significant achievement, particularly if the gene of interest encoded a
membrane protein. At the time, molecular probes such as partial peptide sequences, suitable nucleic acid sequences, or antibodies
were unavailable for most proteins and the Bsodium-phosphate transporter^ was no exception. In contrast, brush-border mem-
brane vesicles and epithelial cell culture experiments had established a reliable set of functional hallmarks that described Na-
dependent phosphate transport activity in some detail. Moreover, aspects of hormonal regulation of phosphate homeostasis could
be recapitulated in these model systems. Expression cloning elegantly combined functional protein expression in Xenopus laevis
oocytes with molecular biology to overcome the lack of molecular probes.
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Introduction
The importance of inorganic phosphate (Pi) to human health
and the hormonal feedback loops to maintain homeostasis were
well established when the two authors, Simona Magagnin and
Andreas Werner, joined the Murer lab in 1991 and 1987, re-
spectively. Detailed studies using brush-border membrane ves-
icles (BBMVs) from kidney and intestine had established func-
tional characteristics of the BNa-Pi cotransporters^ such as ap-
parent affinities for Pi and Na
+ as well as the different pH
dependence of intestinal and renal transport activities.
Moreover, experiments with opossum kidney (OK) cells ele-
gantly confirmed the regulatory impact of hormonal and meta-
bolic factors on Na-dependent Pi transport activity [18]. At that
point, the molecular identity of the Na/Pi cotransporter became
a pressing question and different strategies were initiated to
identify the protein. Approaches comparing protein signals on
2D gels with or without stimulation of Na-Pi transport activity
were pursued, though with limited success: The resulting pro-
tein pattern was too complex and not reproducible enough to
identify differentially expressed signals that would warrant
peptide sequencing [26, 35]. In summer 1987, Heini Murer
organized a meeting in the Swiss Alps (Fürigen) on epithelial
Pi transport that was attended by many of the key figures in the
field. On this occasion, Ernest Wright and Michael Coady
(UCLA) presented the cDNA sequence and primary structure
of the intestinal Na/glucose transporter SGLT1 achieved by
expression cloning [11]. Michael Coady paid a brief visit to
the laboratory in Zürich afterwards and presented us with his
winner’s perspective on how easy and straight forward this
cloning strategy was. The reality was to prove considerably
more tedious and less straightforward than predicted—for ex-
ample, it took us an entire year to confirm the stunningly clear,
first demonstration of Na-dependent Pi cotransport in Xenopus
oocytes injected with rabbit kidney mRNA. Eventually, protein
expression in oocytes proved rather straight forward and then
became an essential tool in the Murer lab to clone and charac-
terize Pi and other solute transporters.
Expression cloning
The expression of proteins in Xenopus laevis oocytes was
pioneered by John Gurdon (University of Cambridge) who
was awarded the 2012 Nobel Prize in Medicine and
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Physiology for his ground-breaking work [9]. In an application
of the original strategy in the mid-1980s, TasukuHonjo (Kyoto
University) and his group injected in vitro-transcribed RNA
from a T cell cDNA library and used the oocyte supernatant
to stimulate growth and colony formation of B cells. By
subdividing the library into smaller and smaller pools, eventu-
ally, a single clone was isolated—encoding interleukin 4—that
conferred biological activity [24]. This strategy was quickly
applied by two groups to the cloning of membrane proteins:
Shigetada Nakanishi’s lab (Kyoto University) used electro-
physiology to isolate a cDNA that induced membrane depo-
larization upon administration of substance K in Xenopus oo-
cytes [20]. At the same time, Ernest Wright’s group (UCLA)
measured the flux of a radioactive glucose analogue to isolate
and characterize a clone encoding the Na-glucose cotransporter
SGLT1 [11]. These three seminal papers provided the corner
stones for the expression cloning strategy using Xenopus oo-
cytes that would become the Bgolden bullet^ for the cloning of
membrane proteins in the pre-genomic era (Fig. 1) [28].
In essence, the technique involves the injection of a few
nanoliters of mRNA into the cytoplasm of oocytes harvested
from frogs (Xenopus laevis) using a pulled glass capillary. The
cells translate the RNA and integrate the resulting protein into
the plasma membrane where its function can be analyzed.
Initially, poly-A-selected mRNA, often length fractionated
using preparative gel electrophoresis, was injected [12, 19].
Interestingly, the mRNAs usually gave robust functional sig-
nals despite the Na-phosphate transporter encoding message
only representing a minimal fraction of the total mixture. In
fact, it is the signal from mRNAs that predicts success or
failure of an expression cloning strategy. Once this key exper-
iment proves successful [31], a cDNA library is constructed
from the relevant mRNA (Fig. 1a). The mix of clones is then
singled out on agar plates, and in a fiddly process using cir-
cular nylon membranes, two exact replicas are taken. The
bacterial clones from the first replica are then pooled, grown,
and the plasmids are extracted. From the plasmid mix, RNA is
synthesized in vitro and then tested in Xenopus oocytes. The
goal is to find one (or more) RNA samples from individual
plates (pools of clones) that significantly induce the uptake of
substrate (Pi) over water-injected controls. The second replica
filter of the Bpositive^ plate is then cut into about 25 squares
containing smaller pools of bacteria and the screening process
is repeated. Eventually, single colonies are picked from the
square that stimulates uptake and tested for function. With
some luck and perseverance, a single clone will eventually
be identified that reliably induces the expected function after
expression in Xenopus oocytes (Fig. 1b).
BStraight forward and easy^—you wish!
Despite its power, expression cloning remained a daunting
task that required cross-discipline methodology and was often
done in collaborations with other laboratories. The first at-
tempt in the Murer laboratory to clone the BNa-Pi transporter^
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Fig. 1 Schematic representation of the expression cloning strategy. a
Summary of the molecular biology arm of the cloning strategy. Reverse
transcription was primed using an oligo-dT-NotI adaptor primer. After
second strand synthesis, SalI linkers were added, followed by NotI
restriction digest. The two different Bsticky^ ends enabled efficient
directional cloning—but excluded the functional cloning of cDNAs that
contain an internal NotI site (as, for example, human NaPi-IIc). bOutline
of the screening strategy using functional expression in Xenopus oocytes.
The left panel explains the steps to successively narrow down the number
of clones. Each of the initial plates contained 600–1000 individual
bacterial colonies. Sib selection, as exemplified in the second screening
step (middle panel), was applied to reduce the number of injections. The
right panel shows the uptake results obtained with the RNA synthesized
from the related plasmid pools
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involved a key collaboration with molecular biologists,
Marilyn Moore, Ned Mantei, and Giorgio Semenza at the
ETH in Zürich. The cDNA library was prepared in their lab
and the resulting in vitro-transcribed RNAwas then coded and
tested blindly in Heini Murer’s laboratory. Ironically, despite
taking all precautions to rule out experimental bias during the
screening steps, NaPi-I turned out to be the wrong clone [33].
It was later shown that the alleged Pi transporter displayed
anion permeability and was related to neuronal vesicular glu-
tamate transporters [1, 29]. NaPi-I did induce phosphate up-
take in oocytes, though many of the previously established
features of Na-phosphate transport were not convincingly
reproduced by NaPi-I [33]. For example, the cloned cDNA
was about 0.5 kb shorter than the mRNA fraction that induced
highest Pi transport in oocytes [31]. Could this be the conse-
quence of poly-A tail shortening or was it a gel artifact?
Moreover, minimal amounts of injectedNaPi-I RNA saturated
Na-dependent Pi uptake in oocytes, contradicting observations
made with SGLT1 and fractionated mRNA where a linear
dose to signal relation was found to 10 ng RNA per oocyte
or even higher [31, 33]. Could it be that the oocytes did not
tolerate a Pi overload and inhibit further expression of the
injected RNA? Nobody could tell at that point. To test a pu-
tative role of NaPi-I in maintaining Pi homeostasis, rabbits
were fed high and low Pi diets and NaPi-I RNA and protein
levels were assessed [6]. To our frustration, no regulatory
effect of Pi on NaPi-I was detected and it became undeniable
that we had put our bets on the wrong clone: In default of a
soul, the devil puts up with a fly—or, in our case, a few Pi
molecules slip through a glutamate transporter if no other
substrate is available. Hence, the measured substrate flux
was a mere by-product and not the physiologically relevant
transport activity of the expressed protein. In retrospect, some
of the problems that tricked us into identifying the Bwrong^
clone have been resolved, others remain enigmatic. The un-
solved ones relate to the biology of oocytes, whereas most of
the solved problems are of technical nature, and both aspects
will be discussed in some detail below.
The good oocyte, the bad oocyte,
and the ugly (and the consequences
of mistaking one for the other)
Quality oocytes were key to reliable protein expression and it
comes as no surprise that the frogs (South African claw-toed
frog, Xenopus laevis) and their precious oocytes were at the
center of perpetual discussions and concerns in Heini Murer’s
lab. Often, the usual Bgood morning!^ was preceded by Bhow
are the oocytes?^ and this was a make-or-break my day ques-
tion. Thousands of injected oocytes and hours of uptake to
assess transport were required to narrow down the selection of
RNAs from bacterial clones and reliable uptake measurements
were essential. BBad^ oocytes had increased Na+-independent
phosphate permeability and displayed uptake rates that were
clearly above controls (water-injected or uninjected oocytes),
and indistinguishable from positive signals. Moreover, such
batches usually showed large variations between individual
cells. As a result, a group of injected Bbad^ oocytes could con-
tain cells with clearly increased transport activity (real signal or
artifact?) as well as oocytes with transport rates close to the
negative controls (non-functional RNA or an oocyte receiving
little or no RNA during injections?). Overinterpretation of such
experiments could easily send the project down the wrong track
and it was often safer to hope for better oocytes and repeat the
entire experiment than taking a bet. Problems mostly occurred
during summer, oocytes had Bspots,^ were soft to inject, or
would not last long enough to show optimal expression.
Unfortunately, during all these times, we were unable to estab-
lish key determinants that would guarantee a constant supply of
Bgood^ oocytes. The influence of a seasonal cycle was
discussed, though several observations complicated the picture:
The frogs were kept at constant water temperature with a 12-h
day/night cycle in a room without windows; moreover, the
problems occurred during European summer with frogs
imported from South Africa, but also with the ones bred in
Germany. The general credo was that happy frogs would give
good oocytes and a lot of consideration was given to food,
husbandry, and pest control. The oocyte users, Simona
Magagnin, Juan Bertran, Daniel Markovich, Manuel Palacin,
and AndreasWerner, were also responsible for feeding the frogs
and cleaning the tanks. Food pellets were imported from
Germany (Horst Kaehler, Hamburg) and the animals were fed
twice a week. The water had to be left for chlorine to evaporate
for at least a day before filling the aquarium; otherwise, the frogs
would develop Bred legs^, a skin disease caused by Aeromonas
bacteria. The frogs’ well-being, their skin, color, and behavior
were monitored closely, and often, the nearby veterinary hospi-
tal was approached for advice. The frogs were looked after more
like pets than lab animals and much of the care was guided by
hearsay and exchange with other oocyte labs rather than pub-
lished guidelines (of which there are many nowadays, for ex-
ample, https://www.med.hku.hk/images/document/04research/
culatr/04_Xenopus_RSPCA%20Guidelines_05.pdf). The less
stringent animal protection rules allowed reusing individual
frogs as long as we were happy with their oocytes. That
implied a surgical procedure to open the skin, fascia, and the
underlying muscular layer to harvest the oocytes. Through a
small opening in the abdomen, a few ovarian sacs were
removed, rinsed in oocyte Ringer’s solution, and further
defolliculated with collagenase [31]. Finishing the procedure
required a few stiches, and the basic surgical tricks my
medical student girlfriend taught me helped with the fiddly
task. Despite the pragmatic and often improvised approach we
took in isolating the Xenopus oocytes, we hardly lost any
animals due to operative surgical errors [27]. Interestingly, the
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frogs never developed wound infections despite minimal effort
to keep the surgical tools sterile and the absence of post-
operative precautions. Similar observations had prompted
Michael Zasloff to investigate the phenomenon that leads to
the discovery of a novel family of antimicrobial peptides from
frog skin, the so-called magainins [36].
In addition to the often unpredictable nature of frogs
and oocytes, the equipment used to inject the cells
was—at least initially—primitive and did little to con-
trol variability. For the first injections, we used a 50-ml
syringe connected to the pulled glass capillary with a
narrow silicone tube to which a vacuum (to aspire the
RNA) and positive pressure (for injections) was applied.
The injected volume was controlled by visually
inspecting the meniscus of the RNA solution moving
along a stripe of graph paper glued to the back of the
capillary. Another matter of concern were impurities in
the RNA or sticky material from the injected oocytes
that easily blocked the capillary tip. In such a no-win
situation, one could either break the tip of the needle
with negative consequences to oocyte survival and sig-
nal variability or change the capillary and risk losing
the precious RNA. With time, the injection equipment
significantly improved; nowadays, there are precise,
purpose-built oocyte injection systems, and even auto-
mated devices are available. Moreover, in the pre-kit era
of molecular biology, the RNA preparations often
contained traces of salts or organic solvents and the
purity of the injected RNA significantly affected oocyte
performance. Despite the many technical improvements,
the rather varied expression of NaPi-II proteins in indi-
vidual oocytes persisted and is likely to depend on the
particular NaPi-II isoform (species of origin) and how
efficiently the particular protein is integrated into the
oocyte membrane.
Molecular biology
At the beginning of the 1990s, molecular biology was still
perceived as a scientific discipline in its own right; the devel-
opment of specialized kits for complex procedures had only
just begun. One of the early kits, the unidirectional cDNA
library construction system, SuperScript from Gibco-BRL,
proved a real game changer: the protocol yielded high-
quality cDNA libraries with 105 clones or more (far exceeding
the number of clones that could realistically be screened) with-
out the requirement of advancedmolecular biology skills (Fig.
1b). Another substantial help were kits to synthesize RNA
using T7 and SP6 RNA polymerases including a Cap ana-
logue, the mMessage mMachine from Ambion becoming
the favored option; however, the latter kits were not available
for the original cloning of rat and human NaPi-II (NaPi-2 and
NaPi-3).1 Though, the challenges did not end with the suc-
cessful isolation of a single, functional cDNA. Sequencing of
kilobases of DNA posed a significant challenge, even with the
reliable Sanger method. To illustrate the scale of the task,
Heini Murer spent a sabbatical semester 1989 in Joseph
Handler’s lab at the NIH (National Institute of Health,
Bethesda) sequencing the renal aldose reductase cDNA of
approximately 1.3 kilobases (kb) [7]. With polyacrylamide-
urea sequencing gels resolving at best 400 bases and primers
costing about 25 times of today’s price, sequencing was time
consuming and expensive. The method of choice at the time
was to chop the insert into small fragments using two or three
frequently cutting restriction enzymes. The resulting pieces
were cloned and Sanger sequenced using vector-encoded
primer binding sites. The resulting patchwork of sequences
was complemented with few sequencing reactions using spe-
cific primers. Assembling the snippets and establishing a con-
sensus sequencewith an open reading framewas the next task,
achieved by pattern recognition. For lack of computer-driven
algorithms, consensus sequences were combined by eye and
intuition, sliding lines of A, T, C, and G along each other, and
searching for noticeable sequence motifs on different frag-
ments to establish an overlap. A compression on a sequencing
gel, caused by CG-rich regions or repeats, could easily shift
the reading frame and it only took a compensatory misinter-
pretation downstream of the original error to get back in
frame. Such a mistake resulted in a stretch of erroneous amino
acids that would be easily spotted if homologous sequences
had been available. Though, without reference, the possibility
of major sequencing errors was real: Whereas the originally
published sequences from rat (NaPi-2/Slc34a1) and human
(NaPi-3/SLC34A1) were correct, the flounder transporter
(NaPi-5/Slc34a2) cloned in collaboration with the Kinne lab-
oratory (Dortmund) was published with a stretch of 98 amino
acids in the wrong reading frame. The mistake was only rec-
ognized and corrected 2 years later [15, 34].
NaPi-IIa, Slc34A1
The cloning of NaPi-I, as disappointing the outcome may
have been, meant that the crucial procedures in expression
cloning such as cDNA library construction, in vitro transcrip-
tion, and the functional assay in Xenopus oocytes had been
extensively tried and tested. For the novel expression cloning
approach, the entire experimental processes including the
1 Initially, the clones were named and numbered in order of appearance; NaPi-
1, NaPi-2, NaPi-3 and so forth. The increasingly confusing mix of NaPis with
clearly distinct structures from various species was later organized into the
protein families NaPi-I (NaPi-1; Slc17A) and NaPi-IIa (NaPi-2 and NaPi-3,
for example; Slc34A1), NaPi-IIb (NaPi-5; Slc34A2), NaPi-IIc (Slc34A3). The
NaPi-III protein families includes the Na-dependent Pi cotransporters Pit1 and
Pit2 (Slc20A1 and Slc20A2).
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molecular biology techniques were performed in the Murer
lab. This endeavor was helped by novel kits which facilitated
the molecular biology arm of expression cloning significantly.
In addition, it was a fortunate coincidence that a second
transporter-oriented laboratory in Zurich with Bruno
Hagenbuch, Bruno Stieger, and Peter Meier embarked on
the expression cloning of bile acid transporters at the same
time we started hunting for NaPi-II [10]. One positive input
was certainly the stimulating exchange about oocytes and
technical pitfalls, more practically, Peter Meier’s group had
an electroporator that gave fabulous transfection rates and
significantly improved the coverage of our cDNA libraries.
Another fortunate coincidence provided us with an excellent
internal control to monitor every aspect of the screening pro-
cess: Juan Bertran and Manuel Palacin, at that time guests in
the Murer laboratory, had just characterized an amino acid
transport activity with renal mRNA. The elicited flux of 3H
arginine was consistently high and virtually without variabil-
ity between individual oocytes [5]. Hence, we screened our
human kidney cDNA library for both phosphate and arginine
transport and the latter proved an excellent indicator for the
quality of the oocytes and confirmed the biological activity of
the injected material. Thanks to the collaborative atmosphere
in the Murer lab and the fact that other cloning projects ran in
parallel, the screening of both rat and human kidney cDNA
libraries progressed without major events. At the end of the
process, we not only isolated clones for rat and human NaPi-
IIa (then NaPi-2 and NaPi-3) [16] but also, quasi as a bonus,
the human amino acid transporter rBAT [4]. Moreover, the
obvious sequence similarities between the rat and the human
clone helped the assembly of the final sequences and sug-
gested a distinct structure-function relationship.
Got a clone, now what?
After barking up the wrong tree with NaPi-1, we were cau-
tious with the introduction of the Breal^ NaPi transporters and
performed a series of experiments to establish the physiolog-
ical relevance of the isolated genes. From the start, the Pi flux
induced by the cloned cDNA/RNAwas impressive; no sign of
BPi overload^ was observed (Fig. 2a). Moreover, transport
activity was highest at neutral pH and decreased when the
uptake solution was acidified, much like the Pi transport ac-
tivity established with renal BBMVs (Fig. 3). The apparent
affinities for Pi and Na
+ were also in agreement with data from
BBMV experiments, and the high expression in kidney, the
signal being most prominent in cortex, concurred with Pi re-
absorption along the renal proximal tubule (Figs. 2 and 3) [16,
23]. The faint band of about 5 kb with mRNA from lung on a
northern blot probed with the human NaPi-IIa cDNAwas the
first sign of human NaPi-IIb, the Bintestinal isoform^. Despite
this appearance, it should take another 5 years until this cDNA
was eventually cloned (Fig. 2b) [13].
An essential question remained unanswered, whether the
identified gene/protein would respond tomediators of Pi homeo-
stasis such as Pi availability and parathyroid hormone (PTH). An
elegant strategy to test the specific contribution of NaPi-IIa to
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overall Pi transport in a mix of renal cortical RNAwas adopted
using RNaseH-mediated hybrid depletion [22]. Kidney RNA
samples were hybridized with NaPi-II-specific DNA oligonu-
cleotides and treated with RNase H, an endonuclease that spe-
cifically hydrolyses RNA hybridized to DNA. The hybrid-
depleted samples were then analyzed by northern blotting and
functional expression in Xenopus oocytes. To our delight,
RNase H treatment significantly reduced both the NaPi-II-
specific band on northern blots as well as Pi transport in injected
oocytes. Moreover, we could show that a low Pi diet stimulated
the abundance of NaPi-II mRNA and also Pi uptake in oocytes
[32]. The so-called Hyp mouse suffers from a proximal tubular
Pi reabsorption defect and proved an excellent system to further
scrutinize the contribution of NaPi-II to maintaining Pi homeo-
stasis. NaPi-IIa was indeed reduced in Hyp mice [30], though
the Hyp gene was previously shown to encode a humoral factor
(but not PTH) rather than the renal phosphate transporter itself
[21]. PTH was found to have little effect on NaPi-II mRNA
levels but to cause a striking reduction of transport protein at
the apical membrane and an intracellular, punctate accumulation
of the transporter [14]. The physiological role was further cor-
roborated by the phenotypic characteristics of NaPi-IIa KOmice
that showed renal Pi wasting, increased VitD3 levels, and a mild
bone phenotype [3]. All these reports firmly established NaPi-
IIa/Slc34A1 as a key player in balancing body Pi levels.
Interestingly, it would take almost 10 years (and probably the
invention of high-throughput DNA sequencing) until the first
humanmutations in SLC34A1 (human NaPi-IIa) were identified
in patient cohorts with renal stones [17, 25].
All these findings convincingly established the mechanism of
Pi reabsorption at the apical membrane of renal proximal tubules;
how Pi crossed the basolateral membrane to reach the renal in-
terstitium remained an unsolved question. Recently, a promising
candidate, Xpr1 (xenotropic and polytropic retroviral receptor 1),
has been suggested [2, 8]. Shortly after cloning the apical trans-
porter, we attempted to express a Pi-efflux activity in oocytes by
injecting proximal tubular mRNA, but failed. The injected oo-
cytes were loaded with 32P, washed, and incubated in Pi-free
solution which was analyzed for leaked counts, though only
insignificant amounts of radioactivity were detected. These ex-
periments indicated that firstly, NaPi-II-mediated transport was
unidirectional under standard uptake conditions (100 mM Na,
1 mM Pi), and secondly, that an expression cloning approach
would unlikely succeed in cloning Bthe basolateral transporter.^
The laboratory
The Murer lab was a thriving environment, home to a mix of
international young scientist from Italy (Simona Magagnin,
Tiziano Verri), Spain (Juan Bertran, Manuel Palacin, and
Victor Sorribas), Australia (Daniel Markovich), the USA
(Chip Montrose, Steve Reshkin), Croatia (Branka Mrkic),
Germany (Corinna Helmle-Kolb, Susanne Quabius, Gerti
Stange), and Switzerland (Jutka Forgo, Andreas Werner,
François Wuarin) including the more senior Juerg Biber and
Heini Murer. The lab space was huge by current standards; we
had dedicated rooms for RNA research, cloning, an oocyte
room, a protein lab, an extended radioactive area, and even
PhD students had proper office space. Quite outrageously ac-
cording to current standards, smoking was permitted in offices
and the coffee corner, also in the Bprotein lab^ but not in DNA
and RNA labs. The rationale was that Bcigarette fumes could
induce mutations when working with nucleic acids^—though
it was not specified whether the samples or the researcher
were at risk. The heart of the lab was arguably the coffee
corner strategically placed between the two wings of the lab;
passing it without interacting with other lab members could
hardly be avoided usually resulting in scientific exchange and
banter. The coffee corner also featured the latest issue of the
daily national newspaper BTages-Anzeiger^ adding reference
to the real world outside the lab. Importantly, the coffee corner
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cotransporter. In vitro-transcribed RNA was expressed in Xenopus oo-
cytes and transport activity measured by radiotracer flux under different
experimental conditions. a Varying concentrations of Pi were included
and transport showed hyperbolic saturation kinetics indicating that one Pi
molecule was transported per cycle (apparent Km 0.170 mM). b Na
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et al. [16]
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was located next to the scintillation counter (probably in bla-
tant violation of any current health and safety standards); this
meant that everyone was immediately informed when a new
clone was born. Since many guest scientists visited the labo-
ratory in Zürich to learn and apply expression cloning, the
Bbaptism^ of new clones was quite frequent event. These suc-
cesses were celebrated in style, with sparkling wine, Swiss
cheese tartlets, and meaty delicacies and compensated for
the long hours in the lab, the setbacks, and frustration with
oocytes.
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